Xigduo

Xigduo combines metformin hydrochloride and dapagliflozin for type 2 diabetes management. This oral medication helps control blood sugar levels when diet and exercise are insufficient. Ideal for adults seeking dual-action glucose regulation. Short-term use under medical supervision recommended.

Xigduo is prescribed to improve blood sugar control in adults with type 2 diabetes. It combines two active ingredients: metformin, which reduces glucose production in the liver, and dapagliflozin, which helps the kidneys remove glucose from the blood. This combination supports better glycemic management alongside diet and exercise. It is not intended for type 1 diabetes or diabetic ketoacidosis.

Users may experience improved energy levels and reduced sugar cravings as blood glucose stabilizes. Some report minor digestive changes when starting the medication, which often lessen over time. Regular monitoring helps assess individual response and tolerance to the combination therapy.

Store Xigduo at room temperature away from moisture and heat. Keep out of reach of children and pets. Do not use if the package is damaged or the medication appears discolored. Inform your healthcare provider about all current medications and medical conditions before starting this treatment.

Xigduo may interact with other diabetes medications, blood pressure drugs, or diuretics. Alcohol consumption can increase the risk of lactic acidosis or low blood sugar. Certain medications, such as CYP3A4 inhibitors, may affect how dapagliflozin works. Always consult a healthcare professional before combining therapies.